LFMD
LifeMD, Inc.
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$3.08
+0.98%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 16.65x
- P/S forward
- 0.66x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 18.64x
- Price / sales
- 0.73x
- Price / cash flow
- -14.98x
Enterprise value
- Enterprise value
- $129.3M
- EV / sales
- 0.63x
- EV / EBITDA
- -9.79x
- EV / EBIT
- -6.76x
- Market cap
- $148.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026